16-02-2023, 21:07

Workhorse Group Sets Fourth Quarter and Full Year 2022

CINCINNATI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an
Globe Newswire16-02-2023, 21:07
16-02-2023, 20:07

Cerberus Sentinel Announces Termination of Public Offering

Scottsdale, Ariz., Feb. 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Cerberus Cyber Sentinel Corporation
Globe Newswire16-02-2023, 20:07
16-02-2023, 19:46

Kura Oncology to Report Fourth Quarter and Full Year 2022

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical
Globe Newswire16-02-2023, 19:46
16-02-2023, 19:44

Arbutus to Report Fourth Quarter and Year End 2022

WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage
Globe Newswire16-02-2023, 19:44
16-02-2023, 19:31

Intellia Therapeutics to Hold Conference Call to Discuss

CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading
Globe Newswire16-02-2023, 19:31
16-02-2023, 19:05

Decibel Therapeutics to Present at the Upcoming SVB

BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company
Globe Newswire16-02-2023, 19:05
16-02-2023, 19:03

Shattuck Labs to Report Fourth-Quarter and Full-Year 2022

AUSTIN, TX & DURHAM, NC, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a
Globe Newswire16-02-2023, 19:03
16-02-2023, 04:17

Sonder Holdings Inc. to Report Fourth Quarter and Full Year

SAN FRANCISCO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Sonder Holdings Inc. (NASDAQ: SOND), a leading next-generation
Globe Newswire16-02-2023, 04:17
16-02-2023, 04:14

Retail Opportunity Investments Corp. Reports 2022 Results

SAN DIEGO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today
Globe Newswire16-02-2023, 04:14
16-02-2023, 04:10

StoneCo Announces Board Changes

GEORGETOWN, Cayman Islands, Feb. 15, 2023 (GLOBE NEWSWIRE) -- StoneCo Ltd. (Nasdaq: STNE) (“Stone” or the “Company”),
Globe Newswire16-02-2023, 04:10
16-02-2023, 04:07

Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug

BOSTON, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage
Globe Newswire16-02-2023, 04:07
16-02-2023, 00:12

Distoken Acquisition Corporation Announces Pricing of $60.0

NEW YORK, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Distoken Acquisition Corporation (Nasdaq: DISTU) (the “Company”), a Cayman
Globe Newswire16-02-2023, 00:12